Related Experiment Video
Updated: Jun 13, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
The Rafts of the Medusa: cholesterol targeting in cancer therapy
M R Freeman1, D Di Vizio, K R Solomon
1Urological Diseases Research Center, Children's Hospital Boston, Boston, MA 02115, USA. michael.freeman@childrens.harvard.edu
Abstract:
In this issue of Oncogene, Mollinedo and co-workers present promising evidence that cholesterol-sensitive signaling pathways involving lipid rafts can be therapeutically targeted in multiple myeloma. Because the pathways considered in their study are used by other types of tumor cells, one implication of this report is that cholesterol-targeting approaches may be applicable to other malignancies.
Insights
Cholesterol-sensitive pathways in lipid rafts show therapeutic potential for multiple myeloma. This suggests cholesterol-targeting strategies may also benefit other cancer types.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Multiple myeloma is a hematologic malignancy.
- Lipid rafts are membrane microdomains crucial for cell signaling.
- Cholesterol is integral to lipid raft structure and function.
Discussion:
- Mollinedo and co-workers investigated cholesterol-sensitive signaling pathways.
- Their research focused on pathways involving lipid rafts.
- These pathways are implicated in the progression of multiple myeloma.
Key Insights:
- Promising evidence suggests therapeutic targeting of cholesterol-sensitive pathways.
- Lipid rafts play a key role in these targeted pathways.
- Cholesterol modulation presents a potential therapeutic strategy.
Outlook:
- The identified pathways are conserved across various tumor cells.
- Cholesterol-targeting approaches may extend to other malignancies.
- This research opens new avenues for cancer treatment development.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenomics: Identification of New Drug Targets
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cell Polarization by Rho Proteins
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
